Tumor necrosis factor inhibits human myogenesis in vitro
about
RIP2, a checkpoint in myogenic differentiation.TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regenerationFibroblast growth factor inducible 14 (Fn14) is required for the expression of myogenic regulatory factors and differentiation of myoblasts into myotubes. Evidence for TWEAK-independent functions of Fn14 during myogenesisThe effects of obesity on skeletal muscle regenerationAmphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE bindingGenomic profiling of messenger RNAs and microRNAs reveals potential mechanisms of TWEAK-induced skeletal muscle wasting in miceDoxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitroCytokine profiling in patients with VCP-associated disease.TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokineMuscle cachexia is regulated by a p53-PW1/Peg3-dependent pathway.Problems and solutions in myoblast transfer therapy.Tumor necrosis factor-alpha inhibits expression of pulmonary surfactant proteinUncoupling of growth inhibition and differentiation in dexamethasone-treated human rhabdomyosarcoma cells.Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells.Cytokines in idiopathic inflammatory myopathies.Phorbol esters selectively and reversibly inhibit a subset of myofibrillar genes responsible for the ongoing differentiation program of chick skeletal myotubes.A ras-dependent pathway abolishes activity of a muscle-specific enhancer upstream from the muscle creatine kinase gene.Transcriptional regulation of acetyl coenzyme A carboxylase gene expression by tumor necrosis factor in 30A-5 preadipocytesExpression of the MyoD1 muscle determination gene defines differentiation capability but not tumorigenicity of human rhabdomyosarcomas.Serum creatinine level, a surrogate of muscle mass, predicts mortality in critically ill patients.Large-scale isolation of human skeletal muscle satellite cells from post-mortem tissue and development of quantitative assays to evaluate modulators of myogenesis.Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.NF-kappaB signaling in skeletal muscle: prospects for intervention in muscle diseasesIron-independent induction of ferritin H chain by tumor necrosis factor.Shared signaling systems in myeloid cell-mediated muscle regeneration.Skeletal muscle regeneration in cancer cachexia.IL-6 impairs myogenic differentiation by downmodulation of p90RSK/eEF2 and mTOR/p70S6K axes, without affecting AKT activityTNFalpha inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways.Systemic inflammation after critical illness: relationship with physical recovery and exploration of potential mechanisms.The omega-3 fatty acid, eicosapentaenoic acid (EPA), prevents the damaging effects of tumour necrosis factor (TNF)-alpha during murine skeletal muscle cell differentiation.Inhibition of myoblast differentiation by tumor necrosis factor alpha is mediated by c-Jun N-terminal kinase 1 and leukemia inhibitory factor.Association of chest radiography findings with host-related genetic factors in patients with nephropathia epidemica.Ectopic expression of p73alpha, but not p73beta, suppresses myogenic differentiation.Regenerating soleus and extensor digitorum longus muscles of the rat show elevated levels of TNF-alpha and its receptors, TNFR-60 and TNFR-80.TNF induces c-fos via a novel pathway requiring conversion of arachidonic acid to a lipoxygenase metabolite.Fibroblast growth factor-2 suppression of tumor necrosis factor alpha-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase.Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor beta.Differential effects of fibroblast growth factor and tumor promoters on the initiation and maintenance of adipocyte differentiation.Effect of myogenic determination on tumorigenicity of chemically transformed 10T1/2 cells.Expression and function of heterotypic adhesion molecules during differentiation of human skeletal muscle in culture
P2860
Q24537698-2DAFA574-0ADB-4F1A-8E8E-FF64CA7AE6EAQ24670970-6F8854F0-A17E-44BB-9BF7-E28CB045FE65Q28294844-B1B80F13-F24D-48F6-8038-9D90C2B9036CQ28393087-961FB7A3-A940-43D8-9F73-5488E604EB03Q28579193-19F49B52-F178-4874-995D-49114869D9DDQ33526358-59D8576F-CD31-4E48-93E3-3CDD94A8FC57Q33614685-94776E07-44E3-4ED9-8049-8C5D917B8032Q33755214-C47CC6BB-752D-448B-B1A4-D5FCD35A7AE4Q34132318-760495DC-60A5-406D-B3CD-7798A8C50DF2Q34573534-B1471556-84D0-4D10-AC06-296435CA656EQ34687663-3014482B-2282-4ED2-B391-DFBB97191134Q35817606-F93B250D-94F9-4308-97A5-BE02EF192C00Q35976398-C324181C-CAFC-4AE5-8075-5F29653CCCA1Q36356932-CDD94569-2360-453B-8829-20F4C15904EBQ36504371-7A3C823A-000C-4DED-B3D2-437905C7398EQ36731232-67918DF1-0FE7-4E6A-BA8A-2C4DE9A8CB38Q36766046-8AC9CC2C-1563-4AD0-96DE-3F8867C55D0CQ36767429-BD38FBA0-69AF-4AA4-974A-D5721E157A45Q36794671-58F7DBCC-2CD1-4CC2-9B3F-480DEF4ECD41Q36829863-BF1EC6F3-8C4A-4ABD-99DA-6CD13189AF14Q36935002-2D5AFBFD-0DBD-4908-9678-41C8CD6B4242Q37042189-4F64B573-F862-4372-95D8-1773E4F576B1Q37075935-591D2A6B-D7D7-42E7-B432-92F00E92D483Q37527030-44FC6130-A94B-47B3-A160-58D9C0A1A5A8Q37618669-6EC42C42-7DC3-4D9A-A3BA-8542CFE6C1DBQ38726702-A5848E5E-84AC-4DB9-8DCE-578D98AB3E4CQ38981101-6330980F-38EC-4BC1-9969-38A75E266D28Q39644786-B253E112-70E4-45B5-9623-9BCEB27CB23BQ39818385-EB40C4CB-E802-47B7-A459-1EF354692314Q39959659-A78ADF30-41DE-421C-9E7C-3D9436FF0D62Q39972513-FBD758CD-E1C3-4DAC-A0A0-54EF4A86E889Q40437812-FF72CFA7-4F8F-428B-ADAA-49C53C39ADB1Q40491757-A2DE94DC-A3F7-4E69-9483-645870013BF3Q40794460-2F9647A5-92B4-4228-A22B-0CF0CA2464CFQ41079611-AE1179A0-CCEF-4F3E-8B11-3551CA2B4C98Q41191845-D6FE8D09-95A1-40C7-91D4-4C41C55AE916Q41568089-DBDCB857-7548-4DBA-A861-8E50EA6E5946Q41587723-F935FBB9-3A32-47B0-927D-819A0629D857Q41706650-3698526E-B6B3-4A5D-940E-A26D5A82D9B5Q41835482-FAE775CA-CC63-4FCD-8CDA-56977DE16BDB
P2860
Tumor necrosis factor inhibits human myogenesis in vitro
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Tumor necrosis factor inhibits human myogenesis in vitro
@en
type
label
Tumor necrosis factor inhibits human myogenesis in vitro
@en
prefLabel
Tumor necrosis factor inhibits human myogenesis in vitro
@en
P2093
P2860
P356
P1476
Tumor necrosis factor inhibits human myogenesis in vitro
@en
P2093
P2860
P304
P356
10.1128/MCB.8.6.2295
P407
P577
1988-06-01T00:00:00Z